LPL - lipoprotein lipase Gene
Also Known as LIPD; HDLCQ11
Species: Homo sapiens
About LPL
This gene has 8 transcripts (splice variants), 244 orthologues, 9 paralogues and is associated with 4 phenotypes. Biased expression in fat (RPKM 753.5) and heart (RPKM 154.2).
Summary
LPL encodes lipoprotein Lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq, Jul 2008]
LPL Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_000237.3 | NP_000228.1 | lipoprotein lipase precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables apolipoprotein binding |
IPI
IPI: Inferred from physical interaction
|
15178420 | GOA |
| enables calcium ion binding |
IDA
IDA: Inferred from direct assay
|
16179346 | GOA |
| enables heparan sulfate proteoglycan binding |
IMP
IMP: Inferred from mutant phenotype
|
11342582 | GOA |
| enables heparin binding |
IDA
IDA: Inferred from direct assay
|
2110364 | GOA |
| enables lipoprotein lipase activity |
IDA
IDA: Inferred from direct assay
|
2110364 | GOA |
| enables lipoprotein lipase activity |
IMP
IMP: Inferred from mutant phenotype
|
25149060 | GOA |
| enables lipoprotein particle binding |
IDA
IDA: Inferred from direct assay
|
11342582 | GOA |
| enables phospholipase A1 activity |
IDA
IDA: Inferred from direct assay
|
7592706 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
20124439 | GOA |
| enables protein homodimerization activity |
IDA
IDA: Inferred from direct assay
|
16179346 | GOA |
| enables signaling receptor binding |
IPI
IPI: Inferred from physical interaction
|
10085125 | GOA |
| enables triacylglycerol lipase activity |
IDA
IDA: Inferred from direct assay
|
182536 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| part of catalytic complex |
IPI
IPI: Inferred from physical interaction
|
30559189 | GOA |
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
2340307 | GOA |
LPL Protein Structure
Lipase: Lipase (30 - 338)
PLAT: PLAT/LH2 domain (343 - 462)
- 0
- 100
- 200
- 300
- 400
- 475 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
lipoprotein lipase |
|
LPL Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
LPL | P06858 | PRMT5 | Homo sapiens | O14744 | 32814053 | |
|
Intra
|
LPL | P06858 | PRMT5 | Homo sapiens | O14744 | 32814053 | |
|
Intra
|
LPL | P06858 | PRMT5 | Homo sapiens | O14744 | 32814053 | |
|
Intra
|
LPL | P06858 | GPIHBP1 | Homo sapiens | Q8IV16 | 20124439 |
LPL Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P81831 | Lipoprotein Lipase Antibody (YA1576) | WB, IHC-P | Human |
| HY-P85262 | Lipoprotein Lipase Antibody (YA4954) | WB; IHC-P; IHC-F; IF-Tissue | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Hyperlipoproteinemia, Type I |
|
|
| Hyperlipidemia, Familial Combined, 3 |
|
|
| Familial Lipoprotein Lipase Deficiency |
|
|
| Hyperlipidemia, Familial Combined, 1 |
|
|
| Familial Hyperlipidemia |
|
|
| Acute Pancreatitis |
|
|
| Hypolipoproteinemia |
|
|
| Pancreatitis |
|
|
| Coronary Heart Disease 1 |
|
|
| Hypertriglyceridemia 1 |
|
|
| Lipase Deficiency, Combined |
|
|
| Abetalipoproteinemia |
|
|
| Hyperlipoproteinemia, Type Iii |
|
|
| Hypoalphalipoproteinemia |
|
|
| Familial Hypercholesterolemia |
|
|
| Lipid Metabolism Disorder |
|
|
| Uremia |
|
|
| Biotinidase Deficiency |
|
|
| Glucose Intolerance |
|
|
| Apolipoprotein C-Ii Deficiency |
|
|
| Type 2 Diabetes Mellitus |
|
|
| Hyperlipoproteinemia, Type V |
|
|
| Hyperalphalipoproteinemia 1 |
|
|
| Alcoholic Pancreatitis |
|
|
| Lecithin:Cholesterol Acyltransferase Deficiency |
|
|
| Cerebrovascular Disease |
|
|
| Abdominal Obesity-Metabolic Syndrome 1 |
|
|
| Glycogen Storage Disease Ia |
|
|
| Xanthomatosis |
|
|
| Hyperglycemia |
|
|
| Coronary Stenosis |
|
|
| Non-Alcoholic Fatty Liver Disease |
|
|
| Hyperlipoproteinemia, Type Iv |
|
|
| Atherosclerosis Susceptibility |
|
|
| Tangier Disease |
|
|
| Heart Disease |
|
|
| Leptin Deficiency Or Dysfunction |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Familial Partial Lipodystrophy |
|
|
| Hyperinsulinism |
|
|
| Familial Apolipoprotein C-Ii Deficiency |
|
|
| Intermittent Claudication |
|
|
| Vascular Disease |
|
|
| Cardiovascular System Disease |
|
|
| Hypobetalipoproteinemia, Familial, 2 |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Apolipoprotein C-Iii Deficiency |
|
|
| Glycogen Storage Disease |
|
|
| Diabetes Mellitus |
|
|
| Nephrotic Syndrome |
|
|
| Prediabetes Syndrome |
|
|
| Hypertension, Essential |
|
|
| Hypercholesterolemia, Familial, 1 |
|
|
| Adenosine Deaminase Deficiency |
|
|
| Platelet Glycoprotein Iv Deficiency |
|
|
| Hypothyroidism |
|
|
| Hypoalphalipoproteinemia, Primary, 1 |
|
|
| Type 1 Diabetes Mellitus |
|
|
| Hypobetalipoproteinemia, Familial, 1 |
|
|
| Aortic Atherosclerosis |
|
|
| Hemophilia B |
|
|
| Lymphoproliferative Syndrome 1 |
|
|
| Myocardial Infarction |
|
|
| American Histoplasmosis |
|
|
| Cystic Fibrosis |
|
|
| Aromatic L-Amino Acid Decarboxylase Deficiency |
|
|
| Overnutrition |
|
|
| Acquired Metabolic Disease |
|
|
| Chronic Kidney Disease |
|
|
| Leukemia, Chronic Lymphocytic |
|
|
| Leber Plus Disease |
|
|
| Dilated Cardiomyopathy |
|
|
| Fundus Dystrophy |
|
|